Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome "BEAUTY-II"

Recruiting

Phase 4 Results N/A

References

Sources for Trial Information